Creative Medical Technology Holdings, Inc.Creative Medical Technology Holdings, Inc.Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪3.62 M‬USD
−3.80USD
‪−5.29 M‬USD
‪9.00 K‬USD
‪1.71 M‬
Beta (1Y)
−0.12
Employees (FY)
4
Change (1Y)
0
Revenue / Employee (1Y)
‪2.25 K‬USD
Net income / Employee (1Y)
‪−1.32 M‬USD

About Creative Medical Technology Holdings, Inc.


CEO
Timothy Warbington
Headquarters
Phoenix
Founded
1998
FIGI
BBG000BCFRJ4
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. Its products include CaverStem, FemCelz, StemSpine and ImmCelz. The company was founded on December 3, 1998 and is headquartered in Phoenix, AZ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CELZ is 2.07 USD — it has increased by 3.50% in the past 24 hours. Watch Creative Medical Technology Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Creative Medical Technology Holdings, Inc. stocks are traded under the ticker CELZ.
CELZ stock has fallen by −9.21% compared to the previous week, the month change is a −18.82% fall, over the last year Creative Medical Technology Holdings, Inc. has showed a −53.38% decrease.
We've gathered analysts' opinions on Creative Medical Technology Holdings, Inc. future price: according to them, CELZ price has a max estimate of 30.00 USD and a min estimate of 30.00 USD. Watch CELZ chart and read a more detailed Creative Medical Technology Holdings, Inc. stock forecast: see what analysts think of Creative Medical Technology Holdings, Inc. and suggest that you do with its stocks.
CELZ reached its all-time high on Apr 5, 2017 with the price of 525,000.00 USD, and its all-time low was 2.12 USD and was reached on Dec 13, 2024. View more price dynamics on CELZ chart.
See other stocks reaching their highest and lowest prices.
CELZ stock is 8.61% volatile and has beta coefficient of −0.12. Track Creative Medical Technology Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is Creative Medical Technology Holdings, Inc. there?
Today Creative Medical Technology Holdings, Inc. has the market capitalization of ‪3.62 M‬, it has decreased by −5.76% over the last week.
Yes, you can track Creative Medical Technology Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
Creative Medical Technology Holdings, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
CELZ earnings for the last quarter are −0.75 USD per share, whereas the estimation was −0.75 USD resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.63 USD per share. See more details about Creative Medical Technology Holdings, Inc. earnings.
Creative Medical Technology Holdings, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
CELZ net income for the last quarter is ‪−1.04 M‬ USD, while the quarter before that showed ‪−1.56 M‬ USD of net income which accounts for 33.23% change. Track more Creative Medical Technology Holdings, Inc. financial stats to get the full picture.
No, CELZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 4.00 employees. See our rating of the largest employees — is Creative Medical Technology Holdings, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Creative Medical Technology Holdings, Inc. EBITDA is ‪−5.52 M‬ USD, and current EBITDA margin is ‪−61.40 K‬%. See more stats in Creative Medical Technology Holdings, Inc. financial statements.
Like other stocks, CELZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Creative Medical Technology Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Creative Medical Technology Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Creative Medical Technology Holdings, Inc. stock shows the sell signal. See more of Creative Medical Technology Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.